THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Mirae Asset Global Investments Co., Ltd.'s Holding History (CIK: 0001569395)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 2,462 Value ($000) $46 Avg Close $16.59 Range $13.50 - $20.33
Q3 2025
Shares 1,947 Value ($000) $28 Avg Close $12.64 Range $10.82 - $14.87
Q2 2025
Shares 1,932 Value ($000) $21 Avg Close $9.72 Range $7.90 - $11.82
Q1 2025
Shares 1,645 Value ($000) $15 Avg Close $9.31 Range $8.35 - $10.90
Q4 2024
Shares 1,639 Value ($000) $16 Avg Close $9.10 Range $7.88 - $10.26
Q3 2024
Shares 1,769 Value ($000) $14 Avg Close $8.66 Range $7.44 - $10.42
Q2 2024
Shares 1,452 Value ($000) $12 Avg Close $9.03 Range $8.13 - $10.44
Q1 2024
Shares 52,876 Value ($000) $557 Avg Close $9.27 Range $8.21 - $11.71
Q4 2023
Shares 45,367 Value ($000) $510 Avg Close $10.06 Range $8.52 - $11.57
Q3 2023
Shares 44,532 Value ($000) $384 Avg Close $9.65 Range $8.25 - $10.59
Q2 2023
Shares 42,539 Value ($000) $440 Avg Close $11.04 Range $9.98 - $12.03
Q1 2023
Shares 53,060 Value ($000) $576 Avg Close $10.57 Range $9.25 - $11.52
Q4 2022
Shares 46,111 Value ($000) $517 Avg Close $10.51 Range $9.56 - $11.83
Q3 2022
Shares 41,351 Value ($000) $419 Avg Close $9.37 Range $7.53 - $11.00
Q2 2022
Shares 34,794 Value ($000) $315 Avg Close $9.21 Range $8.15 - $10.52
Q4 2021
Shares 10,022 Value ($000) $110 Avg Close $8.72 Range $7.30 - $11.24